Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
Author(s) -
David M. Nathan,
Patricia A. Cleary,
Jye-Yu C. Backlund,
Saul Genuth,
John M. Lachin,
Trevor J. Orchard,
Philip Raskin,
Bernard Zinman
Publication year - 2005
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa052187
Subject(s) - medicine , diabetes mellitus , type 2 diabetes , disease , incidence (geometry) , intensive care medicine , type 1 diabetes , surgery , endocrinology , physics , optics
Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of microvascular and neurologic complications of type 1 diabetes. We studied whether the use of intensive therapy as compared with conventional therapy during the Diabetes Control and Complications Trial (DCCT) affected the long-term incidence of cardiovascular disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom